期刊
FERTILITY AND STERILITY
卷 99, 期 4, 页码 1107-1116出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2012.11.038
关键词
Ectopic pregnancy; biomarker; pregnancy of unknown location; proteomics
资金
- National Institutes of Health
- Abbott
- Evofem, Inc.
- NIH [T32HD7440-16, K24HD060687]
Early pregnancy failure is the most common complication of pregnancy, and 1% to 2% of all pregnancies will be ectopic. As one of the leading causes of maternal morbidity and mortality, diagnosing ectopic pregnancy and determining the fate of a pregnancy of unknown location are of great clinical concern. Several serum and plasma biomarkers for ectopic pregnancy have been investigated independently and in combination. The following is a review of the state of biomarker discovery and development for ectopic pregnancy and pregnancy of unknown location. (Fertil Steril (R) 2013;99:1107-16. (C) 2013 by American Society for Reproductive Medicine.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据